{
    "organizations": [],
    "uuid": "a91b7d889316749a9d6ecc37d1e7267fd77815f9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-spero-therapeutics-posts-qtrly-los/brief-spero-therapeutics-posts-qtrly-loss-of-1-59-per-share-idUSASC09UJN",
    "ord_in_thread": 0,
    "title": "BRIEF-Spero Therapeutics Posts Qtrly Loss Of $1.59 Per Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2 (Reuters) - Spero Therapeutics Inc:\n* SPERO THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 OPERATING RESULTS AND PROVIDES PIPELINE UPDATE\n* QTRLY LOSS PER SHARE $1.59 * EXPECTS THAT ITS RESEARCH AND DEVELOPMENT EXPENSES WILL INCREASE THROUGHOUT 2018\n* BELIEVES EXISTING CASH AND CASH EQUIVALENTS WILL FUND OPERATING EXPENSES & CAPITAL EXPENDITURE REQUIREMENTS INTO Q2 2019\n* AS OF DEC 31, 2017, CO HAD CASH AND CASH EQUIVALENTS OF $87.3 MILLION Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)\n ",
    "published": "2018-04-03T04:21:00.000+03:00",
    "crawled": "2018-04-03T16:11:21.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "spero",
        "therapeutic",
        "inc",
        "spero",
        "therapeutic",
        "announces",
        "fourth",
        "quarter",
        "full",
        "year",
        "operating",
        "result",
        "provides",
        "pipeline",
        "update",
        "qtrly",
        "loss",
        "per",
        "share",
        "expects",
        "research",
        "development",
        "expense",
        "increase",
        "throughout",
        "belief",
        "existing",
        "cash",
        "cash",
        "equivalent",
        "fund",
        "operating",
        "expense",
        "capital",
        "expenditure",
        "requirement",
        "q2",
        "dec",
        "co",
        "cash",
        "cash",
        "equivalent",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}